Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21)

Clinical Proteomics

Volumn 11, Issue 1, 2014, Pages

  Costa, Odile ^a   Schneider, Pascale ^a,b   Coquet, Laurent ^c,d   Chan, Philippe ^c   Penther, Dominique ^e   Legrand, Elisabeth ^a   Jouenne, Thierry ^c,d   Vasse, Marc ^a   Vannier, Jean Pierre ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c UNIVERSITY OF ROUEN   (France)

^d Normandie Université   (France)

^e CENTRE HENRI BECQUEREL   (France)

Author keywords

Biomarkers; Calponin; Childhood ALL; OTUB1; Protein casein kinase CK2 and Ikaros

Indexed keywords

CALPONIN 2; CAT EYE SYNDROME CRITICAL REGION PROTEIN 5; CELL PROTEIN; CYSTEIN DESULFURASE ALPHA; DEUBIQUITINASE; DEUBIQUITINATING ENZYME OTUB1; FRUCTOSE BIPHOSPHATE ALDOLASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; ISOVALERYL COA DESHYDROGENASE; METHIONINE ADENOSYLTRANSFERASE 2BETA; MLL SEPTIN LIKE FUSION PROTEIN MSF B; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN BETA; PROTEASOME SUBUNIT BETA TYPE 2; PROTEIN CASEIN KINASE 2ALPHA; PYRUVATE DESHYDROGENASE E1; SEPTIN 9 I4; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER PROGNOSIS; CELL CYCLE ARREST; CELL PROLIFERATION; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ASSOCIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHOBLAST; MASS SPECTROMETRY; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84910664525     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-11-31     Document Type: Article

References (52)

1. Mullighan CG: The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2012, 2012:389-396. Review
2. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995, 86:4263-4269.
3. Li Z, Song C, Ouyang H, Lai L, Payne KJ, Dovat S: Cell cycle-specific function of Ikaros in human leukemia. Pediatr Blood Cancer 2012, 59:69-76.
4. Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M, Coombes KR, Mills GB: Functional proteomic profiling of AML predicts response and survival. Blood 2009, 113:154-164.
5. Luczak M, Kaźmierczak M, Handschuh L, Lewandowski K, Komarnicki M, Figlerowicz M: Comparative proteome analysis of acute myeloid leukemia with and without maturation. J Proteomics 2012, 75:5734-5748.
6. Martins LR, Lúcio P, Silva MC, Gameiro P, Silva MG, Barata JT: On CK2 regulation of chronic lymphocytic leukemia cell viability. Mol Cell Biochem 2011, 356:51-55.
7. Barata JT: The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival. Adv Enzyme Regul 2011, 51:37-49.
8. Scott M, Hyland PL, McGregor G, Hillan KJ, Russell SE, Hall PA: Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene 2005, 24:4688-4700.
9. Jiang N, Kham SK, Koh GS, Suang Lim JY, Ariffin H, Chew FT, Yeoh AE: Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J Proteomics 2011, 74:843-857.
10. Gazy I, Kupiec M: The importance of being modified: PCNA modification and DNA damage response. Cell Cycle 2012, 11:2620-2623.
11. Hossain MM, Hwang DY, Huang QQ, Sasaki Y, Jin JP: Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation. Am J Physiol Cell Physiol 2003, 284:C156-C167.
12. Wu KC, Jin JP: Calponin in non-muscle cells. Cell Biochem Biophys 2008, 52:139-148.
13. Yamamura H, Yoshikawa H, Tatsuta M, Akedo H, Takahashi K: Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis. Int J Cancer 1998, 79:245-250.
14. Katoh Y, Ikura T, Hoshikawa Y, Tashiro S, Ito T, Ohta M, Kera Y, Noda T, Igarashi K: Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein. Mol Cell 2011, 41:554-566.
15. Nordgren KK, Peng Y, Pelleymounter LL, Moon I, Abo R, Feng Q, Eckloff B, Yee VC, Wieben E, Weinshilboum RM: Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics. Drug Metab Dispos 2011, 39:2135-2147.
16. Wang Q, Liu QY, Liu ZS, Qian Q, Sun Q, Pan DY: Inhibition of hepatocelluar carcinoma MAT2A and MAT2beta gene expressions by single and dual small interfering RNA. J Exp Clin Cancer Res 2008, 27:72-80.
17. Jani TS, Gobejishvili L, Hote PT, Barve AS, Joshi-Barve S, Kharebava G, Suttles J, Chen T, McClain CJ, Barve S: Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Res 2009, 19:358-369.
18. Attia RR, Gardner LA, Mahrous E, Taxman DJ, Legros L, Rowe S, Ting JP, Geller A, Kotb M: Selective targeting of leukemic cell growth in vivo and in vitro using a gene silencing approach to diminish S-adenosylmethionine synthesis. J Biol Chem 2008, 283:30788-30795.
19. Yang H, Zheng Y, Li TW, Peng H, Fernandez Ramos D, Martínez-Chantar ML, Rojas AL, Mato JM, Lu SC: Methionine adenosyltransferase 2B, HuR and sirtuin 1 crosstalk impacts on Resveratrol's effect on apoptosis and growth in liver cancer cells. J Biol Chem 2013, 288:23161-23170.
20. Moran-Jones K, Wayman L, Kennedy DD, Reddel RR, Sara S, Snee MJ, Smith R: HnRNP A2 a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res 2005, 33:486-496.
21. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI: The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006, 1765:85-100.
22. Chaudhury A, Chander P, Howe PH: Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles. RNA 2010, 16:1449-1462. Review
23. Ostareck-Lederer A, Ostareck DH: Precision mechanics with multifunctional tools: how hnRNP K and hnRNPs E1/E2 contribute to post-transcriptional control of gene expression in hematopoiesis. Curr Protein Pept Sci 2012, 13:391-400.
24. Wang H, Ye Y, Pan SY, Zhu GY, Li YW, Fong DW, Yu ZL: Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells. Phytomedicine 2011, 18:163-169.
25. Niikura Y, Ogi H, Kikuchi K, Kitagawa K: BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD). Cell Death Differ 2010, 17:1011-1024.
26. Robertson C, Church SW, Nagar HA, Price J, Hall PA, Russell SE: Properties of SEPT9 isoforms and the requirement for GTP binding. J Pathol 2004, 203:519-527.
27. Chacko AD, McDade SS, Chanduloy S, Church SW, Kennedy R, Price J, Hall PA, Russell SE: Expression of the SEPT9-i4 isoform confers resistance to microtubule-interacting drugs. Cell Oncol 2012, 35:85-93.
28. Kim MS, Froese CD, Estey MP, Trimble WS: SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission. J Cell Biol 2011, 195:815-826.
29. Carvou N, Holic R, Li M, Futter C, Skippen A, Cockcroft S: Phosphatidylinositol -and phosphatidylcholine-transfer activity of PITPbeta is essential for COPI-mediated retrograde transport from the Golgi to the endoplasmic reticulum. J Cell Sci 2010, 123:1262-1273.
30. Snoek GT: Phosphatidylinositol transfer proteins: emerging roles in cell proliferation, cell death and survival. IUBMB Life 2004, 56:467-475. Review
31. Riman S, Rizkallah R, Kassardjian A, Alexander KE, Lüscher B, Hurt MM: Phosphorylation of the transcription factor YY1 by CK2α prevents cleavage by caspase 7 during apoptosis. Mol Cell Biol 2012, 32:797-807.
32. Payne KJ, Dovat S: Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog 2011, 16:3-12. Review
33. Dovat S, Song C, Payne KJ, Li Z: Ikaros, CK2 kinase, and the road to leukemia. Mol Cell Biochem 2011, 356:201-207. Review
34. Wiener R, Zhang X, Wang T, Wolberger C: The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 2012, 483:618-622.
35. Sun XX, Challagundla KB, Dai MS: Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J 2012, 31:576-592.
36. Ludwig H, Khayat D, Giaccone G, Facon T: Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies. Cancer 2005, 104:1794-1797.
37. Davis CD, Tsuji PA, Milner JA: Selenoproteins and cancer prevention. Annu Rev Nutr 2012, 32:73-95. Review
38. Carlet M, Janjetovic K, Rainer J, Schmidt S, Panzer-Grümayer R, Mann G, Prelog M, Meister B, Ploner C, Kofler R: Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells. BMC Cancer 2010, 10:638-649.
39. Kowalski W, Nocon D, Gamian A, Kołodziej J, Rakus D: Association of C-terminal region of phosphoglycerate mutase with glycolytic complex regulates energy production in cancer cells. J Cell Physiol 2012, 227:2613-2621.
40. Hulleman E, Kazemier KM, Holleman A, VanderWeele DJ, Rudin CM, Broekhuis MJ, Evans WE, Pieters R, Den Boer ML: Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood 2009, 113:2014-2021.
41. Footz TK, Brinkman-Mills P, Banting GS, Maier SA, Riazi MA, Bridgland L, Hu S, Birren B, Minoshima S, Shimizu N, Pan H, Nguyen T, Fang F, Fu Y, Ray L, Wu H, Shaull S, Phan S, Yao Z, Chen F, Huan A, Hu P, Wang Q, Loh P, Qi S, Roe BA, McDermid HE: Analysis of the cat eye syndrome critical region in humans and the region of conserved synteny in mice: a search for candidate genes at or near the human chromosome 22 pericentromere. Genome Res 2001, 11:1053-1070.
42. Michaud J, Simpson KM, Escher R, Buchet-Poyau K, Beissbarth T, Carmichael C, Ritchie ME, Schütz F, Cannon P, Liu M, Shen X, Ito Y, Raskind WH, Horwitz MS, Osato M, Turner DR, Speed TP, Kavallaris M, Smyth GK, Scott HS: Integrative analysis of RUNX1 downstream pathways and target genes. BMC Genomics 2008, 9:363-380.
43. Jiang N, Koh GS, Lim JY, Kham SK, Ariffin H, Chew FT, Yeoh AE: BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. Exp Hematol 2011, 39:321-329.
44. Trembley JH, Chen Z, Unger G, Slaton J, Kren BT, Van Waes C, Ahmed K: Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors 2010, 36:187-195.
45. Polak R, Buitenhuis M: The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia. Blood 2012, 119:911-923.
46. Ernst A, Avvakumov G, Tong J, Fan Y, Zhao Y, Alberts P, Persaud A, Walker JR, Neculai AM, Neculai D, Vorobyov A, Garg P, Beatty L, Chan PK, Juang YC, Landry MC, Yeh C, Zeqiraj E, Karamboulas K, Allali-Hassani A, Vedadi M, Tyers M, Moffat J, Sicheri F, Pelletier L, Durocher D, Raught B, Rotin D, Yang J, Moran MF, et al.: A strategy for modulation of enzymes in the ubiquitin system. Science 2013, 339:590-595.
47. Schneider P, Costa O, Legrand E, Bigot D, Lecleire S, Grassi V, Vannier JP, Vasse M: In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia. Leuk Res 2010, 34:24-31.
48. Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G, Schmitt C, Lejars O, Schneider P, Demeocq F, Bader-Meunier B, Bernaudin F, Perel Y, Auclerc MF, Cayuela JM, Leverger G, Baruchel A, FRALLE Group: Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol. Haematologica 2012, 97:1743-1750.
49. Van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diáz MG, Malec M, Langerak AW, San Miguel JF, Biondi A: Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13:1901-1928.
50. Schneider P, Vasse M, Corbière C, Legrand E, Marie-Cardine A, Boquet C, Vannier JP: Endostatin variations in childhood acute lymphoblastic leukaemia-comparison with basic fibroblast growth factor and vascular endothelial growth factor. Leuk Res 2007, 31:629-638.
51. Tnani H, López I, Jouenne T, Vicienta CM: Protein composition analysis of oil bodies from maize embryos during germination. J Plant Physiol 2011, 168:510-513.
52. Magdeldin S, Enany S, Yoshida Y, Xu B, Zhang Y, Zureena Z, Lokamani I, Yaoita E, Yamamoto T: Basics and recent advances of two dimensional-polyacrylamide gel electrophoresis. Clin Proteomics 2014, 11:16-26.